In MCF-7 breast cancer cells, FGF2 not only inhibited cell growth and proliferation but also potentiated the effects of anti-cancer drugs by downregulation of BCL2 and upregulation of BAX level, thereby enhancing apoptosis [246,247]. This evidence concerns the gene FGF2 and breast carcinoma.